PRKDC: new biomarker and drug target for checkpoint blockade immunotherapy

BACKGROUND: Immunological checkpoint blockade is effective in treating various malignancies. Identifying predictive biomarkers to assist patient selection for immunotherapy has become a priority in both clinical and research settings. METHODS: Mutations in patients who responded to immunotherapy wer...

全面介紹

Na minha lista:
書目詳細資料
發表在:J Immunother Cancer
Main Authors: Tan, Kien Thiam, Yeh, Chun-Nan, Chang, Yu-Chan, Cheng, Jen-Hao, Fang, Wen-Liang, Yeh, Yi-Chen, Wang, Yu-Chao, Hsu, Dennis Shin-Shian, Wu, Chiao-En, Lai, Jiun-I, Chang, Peter Mu-Hsin, Chen, Ming-Han, Lu, Meng-Lun, Chen, Shu-Jen, Chao, Yee, Hsiao, Michael, Chen, Ming-Huang
格式: Artigo
語言:Inglês
出版: BMJ Publishing Group 2020
主題:
Immunotherapy Biomarkers
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7174075/
https://ncbi.nlm.nih.gov/pubmed/32238472
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2019-000485
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍